Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...

A lawsuit against genomics firm 23andMe is stirring a debate about what the proper role of government is in regulating how ...

The clock is ticking and you only have a few weeks left to file a claim and get part of the 23andMe class-action settlement.

Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” ...

Genetic testing company 23andMe never hit on a sustainable business model and went bankrupt. Now, it's being sold to a non-profit launched by the co-founder, delaying addressing data privacy concerns.

The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing ...

旧金山 - 目前市值为1.4927亿美元的基因检测公司23andMe Holding Co. (OTC: MEHCQ)周五宣布，已与公司联合创始人Anne Wojcicki领导的非营利组织TTAM Research Institute达成最终协议，以3.05亿美元出售其绝大部分资产。根据 InvestingPro 数据显示，该公司在过去十二个月面临重大财务挑战，EBITDA为-1.6489亿美元。

Regeneron is backing away from buying the DNA-testing company after a nonprofit controlled by co-founder Wojcicki made a ...

TTAM Research Institute, a non-profit public benefit company also founded by Wojcicki, won the auction with a $305 million ...

The co-founder of bankrupt genetic analysis company 23andMe won an auction for the firm’s assets, agreeing, along with a ...

DNA data saved: 23andMe co-founder Anne Wojcicki has bid $305 million through a nonprofit to acquire her bankrupt company, ...

Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to TTAM Research ...